Stock Exchange & Press Releases
2023
2023-06-09 13:15
Herantis Pharma Oyj: Managers' Transactions – Antti Vuolanto
Herantis Pharma Plc Company release 9 June 2023 at EEST Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person...
2023-06-09 13:15
Herantis Pharma Oyj: Managers' Transactions – Henri Huttunen
Herantis Pharma Plc Company release 9 June 2023 at 14:15 EEST Herantis Pharma Oyj - Managers' Transactions ____________________________________________...
2023-06-02 14:00
Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel
Herantis Pharma Plc
Company release, 2 June 2023 at 3:00 p.m. EEST The Board of Directors of Herantis Pharma Plc ("Herantis") has on 2 June...
2023-05-23 09:00
Herantis Pharma to participate in Redeye Hosted Events: Investor Lunch and Redeye Growth Day
Herantis Pharma Plc, Press Release, 23 May 2023 at 10:00 A.M. EEST Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company...
Herantis Pharma Plc, Press Release, 2 May 2023 at 11:45 A.M. EEST Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company...
Herantis Pharma Plc Company release, 20 April 2023 at 1:35 p.m. Eastern European Summer Time Herantis Pharma Plc's (“Herantis”) Annual General...
2023-04-19 10:00
Herantis Pharma announces first healthy volunteer dosed in the Phase 1a clinical study for the Parkinson’s disease drug candidate, HER-096
Herantis Pharma Plc, Press release, 19 April 2023 at 11 a.m. EEST The Phase 1a clinical study will assess safety, tolerability, and blood-brain barrier...
2023-04-12 07:00
Herantis Pharma has signed European Innovation Council (EIC) Accelerator grant agreement
Herantis Pharma Plc, Press release, 12 April 2023 at 08:00 a.m. EEST Herantis will receive €2.5 million grant funding and is eligible for up to €15...
2023-04-06 08:00
Herantis Pharma to participate in Nordic Health Summit Japan 2023
Herantis Pharma Plc, Press Release, 6 April 2023 at 09:00 A.M. EEST Herantis Pharma Plc (“Herantis”), developing disease-modifying therapies...
Notice to Convene Herantis Pharma Plc's Annual General Meeting of Shareholders Herantis Pharma Plc Company release 28 March 2023 at 1:45 p.m...